Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP.

about

Compensatory mechanisms in genetic models of neurodegeneration: are the mice better than humans?High plasticity of axonal pathology in Alzheimer's disease mouse models.

P2860

Q35153576-4CE13D5A-90E8-4982-8685-0C4176261F9C Q37630821-99FD4698-5513-44A9-82AD-9909884FD118

P2860

Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP.

Item

http://www.wikidata.org/entity/Q40390510

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Noradrenergic sympathetic spro ...... loidogenic processing of AβPP.

@en

type

Item

label

Noradrenergic sympathetic spro ...... loidogenic processing of AβPP.

@en

prefLabel

Noradrenergic sympathetic spro ...... loidogenic processing of AβPP.

@en

P1476

Noradrenergic sympathetic spro ...... loidogenic processing of AβPP.

@en

P2093

Amy R Nelson

http://www.w3.org/2001/XMLSchema#string

Krystyna Kolasa

http://www.w3.org/2001/XMLSchema#string

Lori L McMahon

http://www.w3.org/2001/XMLSchema#string

P2860

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease.

Sympathetic sprouting in visual cortex stimulated by cholinergic denervation rescues expression of two forms of long-term depression at layer 2/3 synapses.

Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.

Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.

Nerve growth factor gene delivery: animal models to clinical trials.

Nerve growth factor gene therapy in Alzheimer disease.

Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development.

Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.

M1 agonists as a potential disease-modifying therapy for Alzheimer's disease.

P304

867-879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-130608

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24081376

http://www.w3.org/2001/XMLSchema#string

P932

4047988

http://www.w3.org/2001/XMLSchema#string

Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP.

about

P2860

P2860

Noradrenergic sympathetic sprouting and cholinergic reinnervation maintains non-amyloidogenic processing of AβPP.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932